Zentera Therapeutics’ $75 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Tybourne Capital Management on the deal.Zentera Therapeutics, a clinical-stage biopharmaceutical company, completed a $75 million Series B financing. Founding investors OrbiMed…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now